Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
On Nov. 21, Guggenheim analyst Ronald Jewsikow maintained Aptiv with a Buy and lowered the price target from $87 to $73.On CNBC's "Mad Money Lightning Round," Jim Cramer said Reddit, Inc. (NYSE:RDDT) is "fabulous," adding that he is not a seller.
在CNBC的《瘋狂金錢快閃》中，吉姆·克萊默表示，Reddit, Inc. (紐交所: RDDT) "非常好"，並補充說他不是賣出者。
According to a report last week, shareholder Advance Magazine Publishers, Inc. plans to establish a credit facility using its stake in the company. Yahoo Finance reported that the publishing company aims to make as much as $1.2 billion in a sale of 7.8 million shares for between $145.38 and $148.54 per share.
根據上週的一份報告，股東Advance Magazine Publishers, Inc.計劃利用其在公司的股份建立信貸額度。Yahoo Finance報道，該出版公司計劃通過以每股145.38美元至148.54美元的價格出售780萬股，最多籌集12億。
"I am concerned that many auto parts may be made in China, we don't know," Cramer said when asked about Aptiv PLC (NYSE:APTV). He recommended going with AutoZone (NYSE:AZO).
當被問及aptiv plc (紐交所: APTV)時，克萊默表示："我擔心許多汽車零件可能是在中國製造的，我們不知道。"他建議選擇汽車地帶（紐交所: AZO）。
On Nov. 21, Guggenheim analyst Ronald Jewsikow maintained Aptiv with a Buy and lowered the price target from $87 to $73.
11月21日，古根海姆分析師羅納德·朱西科維維保持對aptiv的買入評級，並將目標價從87美元下調至73美元。
When asked about Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), he said, "Now, I think, at five, it's, it is worthwhile speculation."
當被問及Recursion Pharmaceuticals, Inc. (納斯達克: RXRX)時，他表示："現在，我認爲，以五來說，這是值得的投機。"
On Nov. 20, Needham analyst Gil Blum reiterated Recursion Pharmaceuticals with a Buy and maintained a price target of $11.
11月20日，Needham分析師吉爾·布盧姆重申對Recursion Pharmaceuticals的買入評級，並維持11美元的目標價。
"Not enough specialty," Cramer said when asked about ZoomInfo Technologies Inc. (NASDAQ:ZI). "Let's pass on that."
"特色不夠，"克萊默在被問及zoominfo technologies inc. (納斯達克: ZI)時表示。"我們就不跟了。"
On Nov. 12, ZoomInfo Technologies reported better-than-expected earnings for its third quarter.
在11月12日，zoominfo technologies報告了其第三季度的業績好於預期。
Dow Inc. (NYSE:DOW) is a "tough" one, the "Mad Money" host said. "If you don't have growth, and you sell at 21 times earnings, you're not going to be able to do anything."
陶氏化學生意（紐交所:DOW）是一個"艱難"的選擇，"瘋狂金錢"主持人表示。"如果你沒有增長，而你的市盈率是21倍，那麼就沒辦法做任何事情。"
On Nov. 8, Piper Sandler analyst Charles Neivert maintained Dow with an Overweight rating and lowered the price target from $62 to $60.
11月8日，派傑投資分析師查爾斯·奈弗特對陶氏維持了超重評級，並將目標價格從62美元下調至60美元。
Cramer said, "Accounting irregularities equal sell," when asked about Super Micro Computer (NASDAQ:SMCI).
克拉默在被問及超微電腦（納斯達克:SMCI）時表示，"會計不規範等於賣出。"
Super Micro Computer experienced a significant stock decline on Tuesday, after announcing the termination of two critical loan agreements with major financial institutions.
超微電腦宣佈終止與主要金融機構的兩項關鍵貸款協議後，週二股價大幅下跌。
Price Action:
價格行動：
- Aptiv shares fell 3.2% to settle at $55.28 on Tuesday.
- Reddit shares fell 4.4% to close at $135.61.
- Recursion Pharmaceuticals shares declined 1.8% to close at $5.89.
- ZoomInfo shares gained 0.2% to close at $10.89.
- Dow shares fell 2.9% to settle at $44.54 on Tuesday.
- Super Micro Computer shares dipped 10.4% to settle at $34.43 during the session.
- aptiv plc的股票週二下跌3.2%，收於55.28美元。
- Reddit的股票下跌4.4%，收於135.61美元。
- Recursion Pharmaceuticals的股票下跌1.8%，收於5.89美元。
- zoominfo的股價上漲了0.2%，收於10.89美元。
- 陶氏化學的股價下跌了2.9%，在週二收於44.54美元。
- 超微電腦的股價在交易中下跌了10.4%，收於34.43美元。
- Jim Cramer: Linde Is A 'Terrific' Company, Sees Another Stock Up 75% As 'Not Done'
- 吉姆·克萊默：linde是一家「優秀」的公司，認爲另一隻股票上漲75%還「沒有結束」
Photo: Shutterstock
Photo: shutterstock
